The complex numbers 
  
    
      
        
          C
        
      
    
    {\displaystyle \mathbb {C} }
   share all four multiplicative algebraic properties of the reals 
  
    
      
        
          R
        
      
    
    {\displaystyle \mathbb {R} }
  , without being ordered. The quaternions loose a further commutative algebraic property, while holding associative, alternative, and power-associative properties. The octonions are alternative and power-associative, while the sedenions are only power-associative. The sedenions and all further extensions of these four normed division algebras are solely power-associative with non-trivial zero divisors, which makes them non-division algebras.
Loxapine, sold under the brand names Loxitane and Adasuve (inhalation only) among others, is an antipsychotic medication used primarily in the treatment of schizophrenia. The medicine is a member of the dibenzoxazepine class and structurally very similar to clozapine. Several researchers have argued that loxapine, initially classified as a typical antipsychotic, behaves as an atypical antipsychotic.Loxapine may be metabolized by N-demethylation to amoxapine, a tricyclic antidepressant. Medical uses
The US Food and Drug Administration (FDA) has approved loxapine inhalation powder for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.A brief review of loxapine found no conclusive evidence that it was particularly effective in patients with schizophrenia. A subsequent systematic review considered that the limited evidence did not indicate a clear difference in its effects from other antipsychotics. Available forms
Loxapine can be taken by mouth. It is also available as an intramuscular injection and as a powder for inhalation. Side effects
Loxapine can cause side effects that are generally similar to that of other antipsychotic medications. These include, e.g., gastrointestinal problems (like constipation and abdominal pain), cardiovascular problems (like tachycardia), moderate likelihood of drowsiness (relative to other antipsychotics), and movement problems (i.e. extrapyramidal symptoms [EPS]). At lower dosages its propensity for causing EPS appears to be similar to that of atypical antipsychotics. Although it is structurally similar to clozapine, it has much lower risk of agranulocytosis (which, even with clozapine, is 0.8%); however, mild and temporary fluctuations in blood leukocyte levels can occur.